Activation and inhibition of the proteasome by betulinic acid and its derivatives

FEBS Letters

Volumn 581, Issue 25, 2007, Pages 4955-4959

  Huang, Li ^a   Ho, Phong ^a   Chen, Chin Ho ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Betulinic acid; Proteasome activator; Proteasome inhibitor

Indexed keywords

BETULIC ACID; CHYMOTRYPSIN; PROTEASOME; PROTEASOME INHIBITOR;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODIFICATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL;

CELL LINE, TUMOR; CHYMOTRYPSIN; ENZYME ACTIVATION; HUMANS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; SUCCINATES; TRITERPENES;

EID: 34948849213     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.09.031     Document Type: Article

References (30)

1. Goldberg A.L., and Dice J.F. Intracellular protein degradation in mammalian and bacterial cells. Annu. Rev. Biochem. 43 (1974) 835-869
2. Goldberg A.L., and St John A.C. Intracellular protein degradation in mammalian and bacterial cells: part 2. Annu. Rev. Biochem. 45 (1976) 747-803
3. Rechsteiner M., and Hill C.P. Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors. Trends Cell Biol. 15 (2005) 27-33
4. Hill C.P., Masters E.I., and Whitby F.G. The 11S regulators of 20S proteasome activity. Curr. Top. Microbiol. Immunol. 268 (2002) 73-89
5. Ustrell V., Hoffman L., Pratt G., and Rechsteiner M. PA200, a nuclear proteasome activator involved in DNA repair. EMBO J. 21 (2002) 3516-3525
6. Rechsteiner M., Realini C., and Ustrell V. The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochem. J. 345 (2000) 1-15
7. DeMartino G.N., and Slaughter C.A. The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274 (1999) 22123-22126
8. Voges D., Zwickl P., and Baumeister W. The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68 (1999) 1015-1068
9. Borissenko L., and Groll M. 20S proteasome and its inhibitors: crystallographic knowledge for drug development. Chem. Rev. 107 (2007) 687-717
10. Kane R.C., Bross P.F., Farrell A.T., and Pazdur R. Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy. Oncologist 8 (2003) 508-513
11. Yang H., Chen D., Cui Q.C., Yuan X., and Dou Q.P. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res. 66 (2006) 4758-4765
12. Yang H., Shi G., and Dou Q.P. The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry. Mol. Pharmacol. 71 (2007) 426-437
13. Tanaka K., Ii K., Ichihara A., Waxman L., and Goldberg A.L. A high molecular weight protease in the cytosol of rat liver. I. Purification, enzymological properties, and tissue distribution. J. Biol. Chem. 261 (1986) 15197-15203
14. Wilk S., and Chen W.E. Synthetic peptide-based activators of the proteasome. Mol. Biol. Rep. 24 (1997) 119-124
15. Kashiwada Y., Hashimoto F., Cosentino L.M., Chen C.H., Garrett P.E., and Lee K.H. BA and dihydroBA derivatives as potent anti-HIV agents. J. Med. Chem. 39 (1996) 1016-1017
16. Hashimoto F., Kashiwada Y., Cosentino L.M., Chen C.H., Garrett P.E., and Lee K.H. Anti-AIDS agents-XXVII. Synthesis and anti-HIV activity of BA and dihydroBA derivatives. Bioorg. Med. Chem. 5 (1997) 2133-2143
17. Holz-Smith S.L., Sun I.C., Jin L., Matthews T.J., Lee K.H., and Chen C.H. Role of human immunodeficiency virus (HIV) type 1 envelope in the anti-HIV activity of the BA derivative IC9564. Antimicrob. Agents Chemother. 45 (2001) 60-66
18. Sun I.C., Chen C.H., Kashiwada Y., Wu J.H., Wang H.K., and Lee K.H. Anti-AIDS agents 49. Synthesis, anti-HIV, and anti-fusion activities of IC9564 analogues based on BA. J. Med. Chem. 45 (2002) 4271-4275
19. Mayaux J.F., Bousseau A., Pauwels R., Huet T., Henin Y., Dereu N., Evers M., Soler F., Poujade C., De Clercq E., and Le Pecq J.B. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells. Proc. Natl. Acad. Sci. 91 (1994) 3564-3568
20. Soler F., Poujade C., Evers M., Carry J.C., Henin Y., Bousseau A., Huet T., Pauwels R., De Clercq E., Mayaux J.F., Le Pecq J.B., and Dereu N. BA derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry. J. Med. Chem. 39 (1996) 1069-1083
21. Huang L., Xiong Y., Aiken C., and Chen C.H. Bifunctional anti-HIV-1 small molecules with two novel mechanisms of action. Antimicrob. Agents Chemother. 48 (2004) 663-665
22. Huang L., Ho P., Lee K.H., and Chen C.H. Synthesis and anti-HIV activity of bi-functional BA derivatives. Bioorg. Med. Chem. 14 (2006) 2279-2289
23. Chintharlapalli S., Papineni S., Ramaiah S.K., and Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 67 (2007) 2816-2823
24. Pisha E., Chai H., Lee I.S., Chagwedera T.E., Farnsworth N.R., Cordell G.A., Beecher C.W., Fong H.H., Kinghorn A.D., Brown D.M., Wani M.C., Wall M.E., Hieken T.J., Das Gupta T.K., and Pezzuto J.M. Discovery of BA as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1 (1995) 1046-1051
25. Fulda S., Jeremias I., Pietsch T., and Debatin K.M. BA: a new chemotherapeutic agent in the treatment of neuroectodermal tumors. Klin. Padiatr. 211 (1999) 319-322
26. Fulda S., Friesen C., Los M., Scaffidi C., Mier W., Benedict M., Nunez G., Krammer P.H., Peter M.E., and Debatin K.M. BA triggers CD95 (APO-1/Fas)-and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. Cancer Res. 57 (1997) 4956-4964
27. Schmidt M.L., Kuzmanoff K.L., Ling-Indeck L., and Pezzuto J.M. BA induces apoptosis in human neuroblastoma cell lines. Eur. J. Cancer 33 (1997) 2007-2010
28. Li F., Goila-Gaur R., Salzwedel K., Kilgore N.R., Reddick M., Matallana C., Castillo A., Zoumplis D., Martin D.E., Orenstein J.M., Allaway G.P., Freed E.O., and Wild C.T. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proc. Natl. Acad. Sci. USA 100 (2003) 13555-13560
29. Zhou J., Xiong Y., Dismuke D., Forshey B.M., Lundquist C., Lee K.H., Aiken C., and Chen C.H. Pharmacologic inhibition of HIV-1 replication by a novel mechanism: specific interference with the final step of virion maturation. J. Virol. 78 (2004) 922-929
30. Seo H., Sonntag K.C., Kim W., Cattaneo E., and Isacson O. Proteasome activator enhances survival of huntington's disease neuronal model cells. PLoS ONE. 2 (2007) e238